Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Mitoglitazone (M160)

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2022
ITP median % ↑ (♂, best cohort)
7.80
ITP median % ↑ (♀, best cohort)
-5.80
ITP P90 % ↑ (♂, best cohort)
-0.10
ITP P90 % ↑ (♀, best cohort)
-7.80
ITP sex effect
female
ITP dose (ppm)
300 ppm
ITP age at start (mo)
18 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (1)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2022C2022300 ppm7.8%-5.8%-0.1%-7.8%↗ paper